ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,071.63
      0.02%
      US Tech 100
      16,868.40
      -0.79%
      Dow Jones
      38,460.92
      -0.11%
      Brent Oil
      86.965
      -0.29%
      Bitcoin
      64,282.35
      -0.01%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Oncolytics Biotech Inc (ONCY)

      7. Oncolytics Biotech Inc (ONCY) News

      ONCY

      Oncolytics Biotech (ONCY)

      Oncolytics Biotech Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ONCY
      DateTimeSourceHeadlineSymbolCompany
      03/07/20244:06PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      03/05/20241:08PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      03/04/202412:37PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      02/28/20241:09PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      02/14/20248:30AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      01/09/20248:44AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      01/04/20241:01PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      12/07/202310:37AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      11/09/20231:21PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      11/09/20231:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      11/03/20232:01PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      11/03/202311:18AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      11/03/202311:17AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      10/23/202312:33PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      10/23/202312:26PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      10/20/20233:07PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      10/16/20231:20PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      09/26/202312:32PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      09/26/20238:00AMPR Newswire (US)THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTSNASDAQ:ONCYOncolytics Biotech Inc
      09/19/20235:28PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      09/06/202312:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      08/14/20239:49AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      08/14/20238:41AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      08/04/20233:14PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      08/04/20232:57PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
      06/22/20239:23AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ONCYOncolytics Biotech Inc
      06/05/20237:31AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ONCYOncolytics Biotech Inc
      05/26/202311:43AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ONCYOncolytics Biotech Inc
      05/26/20236:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ONCYOncolytics Biotech Inc
      05/11/20233:30PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ONCYOncolytics Biotech Inc
       Showing the most relevant articles for your search:NASDAQ:ONCY